AzurRx BioPharma Inc (AZRX)

0.77 -0.02  -2.84% NASDAQ Dec 2, 16:59 USD
View Full Chart
Price Chart
View All Events


Date Type Description
09/11/2020 09:00 EST Misc AzurRx BioPharma Inc Annual General Meeting for 2020
08/13/2020 Earnings AzurRx BioPharma Inc Second Quarter Earnings Results for 2020
12/19/2019 09:00 EST Misc AzurRx BioPharma Inc Annual General Meeting for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Aug. 13, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP).





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.